Campbell Newman Asset Management Inc Corcept Therapeutics Inc Transaction History

Campbell Newman Asset Management Inc

$1.25 Billion
Q3 2024

A detailed history of Campbell Newman Asset Management Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Campbell Newman Asset Management Inc holds 49,374 shares of CORT stock, worth $2.35 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

49,374

Previous 50,183 1.61%

Holding current value

$2.35 Million

Previous $1.63 Million 40.12%

% of portfolio

0.18%

Previous 0.13%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$29.51 - $46.26 $23,873 - $37,424	-809 Reduced 1.61%	49,374 $2.28 Million
Q2 2024 Jul 18, 2024	SELL	$22.21 - $34.48 $1,887 - $2,930	-85 Reduced 0.17%	50,183 $1.63 Million
Q1 2024 Apr 16, 2024	BUY	$21.1 - $27.46 $24,919 - $32,430	1,181 Added 2.41%	50,268 $1.27 Million
Q4 2023 Jan 24, 2024	BUY	$24.82 - $32.88 $5,237 - $6,937	211 Added 0.43%	49,087 $1.59 Million
Q3 2023 Oct 19, 2023	SELL	$21.97 - $33.8 $18,916 - $29,101	-861 Reduced 1.73%	48,876 $1.33 Million
Q2 2023 Jul 24, 2023	BUY	$21.44 - $25.15 $23,412 - $27,463	1,092 Added 2.24%	49,737 $1.11 Million
Q1 2023 Apr 28, 2023	BUY	$19.2 - $24.47 $8,812 - $11,231	459 Added 0.95%	48,645 $1.05 Million
Q4 2022 Jan 26, 2023	BUY	$19.95 - $29.96 $30,483 - $45,778	1,528 Added 3.27%	48,186 $0
Q3 2022 Oct 27, 2022	BUY	$24.7 - $29.12 $27,565 - $32,497	1,116 Added 2.45%	46,658 $1.2 Million
Q2 2022 Jul 19, 2022	BUY	$17.33 - $25.3 $34,209 - $49,942	1,974 Added 4.53%	45,542 $1.08 Million
Q1 2022 Apr 27, 2022	BUY	$16.53 - $25.21 $13,984 - $21,327	846 Added 1.98%	43,568 $981,000
Q4 2021 Jan 24, 2022	BUY	$17.1 - $23.34 $19,254 - $26,280	1,126 Added 2.71%	42,722 $846,000
Q3 2021 Oct 15, 2021	BUY	$19.68 - $22.53 $42,843 - $49,047	2,177 Added 5.52%	41,596 $819,000
Q2 2021 Jul 16, 2021	BUY	$19.97 - $24.43 $40,179 - $49,153	2,012 Added 5.38%	39,419 $867,000
Q1 2021 Apr 19, 2021	BUY	$23.49 - $30.56 $41,577 - $54,091	1,770 Added 4.97%	37,407 $890,000
Q4 2020 Feb 01, 2021	BUY	$16.78 - $27.3 $45,003 - $73,218	2,682 Added 8.14%	35,637 $932,000
Q3 2020 Oct 20, 2020	BUY	$12.46 - $19.98 $7,613 - $12,207	611 Added 1.89%	32,955 $574,000
Q2 2020 Jul 27, 2020	BUY	$11.0 - $18.26 $3,344 - $5,551	304 Added 0.95%	32,344 $544,000
Q1 2020 Apr 27, 2020	SELL	$10.11 - $14.04 $15,569 - $21,621	-1,540 Reduced 4.59%	32,040 $381,000
Q4 2019 Jan 22, 2020	SELL	$12.06 - $16.96 $639 - $898	-53 Reduced 0.16%	33,580 $406,000
Q3 2019 Oct 23, 2019	SELL	$10.41 - $14.66 $2,821 - $3,972	-271 Reduced 0.8%	33,633 $475,000
Q2 2019 Jul 24, 2019	BUY	$9.78 - $12.76 $22,171 - $28,926	2,267 Added 7.17%	33,904 $378,000
Q1 2019 Apr 09, 2019	BUY	$10.03 - $15.71 $8,174 - $12,803	815 Added 2.64%	31,637 $371,000
Q4 2018 Jan 18, 2019	BUY	$11.29 - $17.19 $36,669 - $55,833	3,248 Added 11.78%	30,822 $412,000
Q3 2018 Oct 15, 2018	BUY	$12.27 - $15.65 $338,332 - $431,533	27,574 New	27,574 $387,000

Others Institutions Holding CORT

# of Institutions

315

Shares Held

88.1M

Call Options Held

1.07M

Put Options Held

973K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.1B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell Newman Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Campbell Newman Asset Management Inc with notifications on news.

Account

Campbell Newman Asset Management Inc Corcept Therapeutics Inc Transaction History